REQUEST A DEMO
Total
USD $0.00
Search more companies

Unilabs Slovensko, s. r. o. (Slovakia)

Main Activities: Medical and Diagnostic Laboratories
Full name: Unilabs Slovensko, s. r. o. Profile Updated: April 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Unilabs Slovensko, s. r. o. is a company located in Martin, Slovakia. It has been providing laboratory diagnostic services in Slovakia since 1997. The company expanded its expertise from clinical biochemistry to microbiology, medical genetics, immunology, and pathology. In 2017, it became part of the multinational laboratory group Unilabs, headquartered in Switzerland. In February 2021, the company formally changed its business name to Unilabs Slovensko, s. r. o. Unilabs is one of the largest diagnostic laboratory networks in Europe, formed in 1987 by the merger of three Swiss diagnostic laboratories. It has since grown throughout Europe and in 2007 merged with the significant imaging diagnostics company Capio, established in Sweden, Norway, Finland, Denmark, and the United Kingdom. Unilabs has become a European leader in diagnostics and expanded its portfolio to become a global operator in genetic medicine and pathology. The company employs approximately 12,700 people worldwide, including 1,520 doctors, and operates more than 250 laboratories. It conducts over 200 million tests annually. Unilabs Slovensko benefits from this partnership, particularly in terms of know-how and access to the latest technical equipment and diagnostics. The company has introduced several firsts in Slovakia, including drive-thru testing for COVID-19 via PCR, precise laboratory ELISA testing for SARS-CoV-2 antibodies, and precise laboratory antigen testing. In 2021, Unilabs Slovensko also became the first to offer PCR testing through gargling. The company's laboratories process samples from nearly 12,500 patients daily, conducting over 90,000 examinations. Unilabs Slovensko ensures the reliability of laboratory test results through internal and external quality control and accreditation of its laboratories. It also provides its own transportation service for efficient transport of samples throughout Slovakia. The company invests in education and collaborates with the Slovak Medical University, with its central laboratory in Bratislava and pathology department in Martin serving as training bases. Unilabs Slovensko is a contractual partner of all health insurance companies in Slovakia and provides services to 80 hospitals, clinics, and over 7,000 doctors.

Headquarters
Zaborskeho 2
Martin; Zilinsky; Postal Code: 03601

Contact Details: Purchase the Unilabs Slovensko, s. r. o. report to view the information.

Website: http://www.alphamedical.sk

Basic Information
Total Employees:
Purchase the Unilabs Slovensko, s. r. o. report to view the information.
Outstanding Shares:
Purchase the Unilabs Slovensko, s. r. o. report to view the information.
Registered Capital:
Purchase the Unilabs Slovensko, s. r. o. report to view the information.
Financial Auditors:
Purchase the Unilabs Slovensko, s. r. o. report to view the information.
Incorporation Date:
March 25, 1996
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Subsidiaries
Alpha medical patologia, s.r.o.
100%
Histopatologia, a.s.
100%
Klinicka patologia Presov, s. r.o.
100%
Company Performance
Financial values in the chart are available after Unilabs Slovensko, s. r. o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-17.94%
Total operating revenue
-17.95%
Operating profit (EBIT)
N/A
EBITDA
-51.03%
Net Profit (Loss) for the Period
N/A
Total assets
-0.77%
Total equity
-7.08%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
6.06%
Quick Ratio
-0.38%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?